Aprea Therapeutics Inc
APRE
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.38M
Close$
$2.23
167.8% upside
Current Fair Value
167.8% upsideUndervalued by 167.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.38 Million |
|---|---|
| Enterprise Value | $-30,849,233.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.93 |
| Beta | 1.59 |
| Outstanding Shares | 53,483,504 |
Return
| Return on Equity | -31.99% |
|---|---|
| Return on Assets | -29.10% |
| Return on Invested Capital | -32.24% |
Valuation & Multiples
| P/E Ratio | -0.65 |
|---|---|
| PEG | -5.97 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -9244.6 |
| Enterprise Value to EBIT | 2.44 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
$253,000
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$307,500
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.20%▼ 21.73% |
|---|---|
| Total Invested | $1.71M▲ 18.39% |
| Investors Holding | 220% |
ESG Score
No data